Firefighter™ PTCA Balloon Dilatation Catheter Granted CE Mark

Shanghai, China - Firefighter™ PTCA Balloon Dilatation Catheter ("Firefighter™"), in-house developed by Shanghai MicroPort Medical (Group) Co ("MicroPort®"), received the CE Mark on July 15, marking the official entry of MicroPort®'s new generation coronary balloon dilatation catheter into the European Union ("EU") market.
 
Firefighter™ is used in percutaneous transluminal coronary angioplasty ("PTCA") for coronary dilatation. It can be used in combination with MicroPort®'s in-house developed Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®"). As the new generation of high-end balloon catheter MicroPort® elaborately designed after JIVE™ PTCA and FOXTROT™ PRO PTCA Balloon Dilatation Catheters, Firefighter™ has much smaller balloon crossing profile and softer material compared to competitors' products, allowing the product to repetitiously cross stenotic and tortuous lesions with excellent crossability. Its super-tiny design-size makes it possible for two balloon catheters to be accommodated in a 5F guiding catheter, which facilitates doctors to perform complex operations such as kissing. The Firefighter™ that gained the CE Mark this time has a total of 43 specifications, covering 12 diameters (1.0mm-4.0mm), and four lengths (6mm, 10mm, 15mm and 20mm).
 
As Firefighter™ is permitted to be launched in the EU market, MicroPort® will further diversify our cardiovascular product line, with accelerated product upgrading. With its outstanding performance, Firefighter™ is expected to help MicroPort® further consolidate and expand its coronary products' market share in the overseas market.